NOTICE OF ALLOWANCE - ISSUED
issued
on 02 Jul 2024
Last Applicant/ Owned by
50 Health Sciences
Stony Brook
NY
11790
Serial Number
98153543 filed on 28th Aug 2023
Registration Number
N/A
Correspondent Address
Anthony E. Bennett
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
LINEAIVT
Scientific research; biotechnology research and development; biological research; biomedical research; research and development services in the field of DNA based medications and therapies; DNA expression vector design and development for others; biotech and clinical research and development of DNA based medications and therapies mRNA production platform and in vivo transcription, namely, biochem Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research; biotechnology research and development; biological research; biomedical research; research and development services in the field of DNA based medications and therapies; DNA expression vector design and development for others; biotech and clinical research and development of DNA based medications and therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [040]
Treatment & Processing of Materials Services
Custom manufacturing of DNA expression vectors, namely plasmids, viruses and biological constructs designed for gene expression in cells, for others; custom biological manufacturing services for others, namely, manufacturing of pharmaceuticals using biological organisms in the manufacturing process, namely, nucleic acids, DNA, RNA, and mRNA; custom manufacture of pharmaceuticals using biological organisms in the manufacturing process, namely, DNA and mRNA for others as components of in vitro diagnostic tests and for preclinical nucleic acid-based drug development in the fields of adoptive cell therapies as CAR T and TCR T therapies, anti-viral and cancer DNA vaccines, RNA therapies, clustered regularly interspaced short palindromic repeats (CRISPR) based therapies, and gene therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Nucleic acid sequences for medical purposes; nucleic acid sequences and chemical reagents for medical and veterinary purposes; Biological preparations for the treatment of cancer
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
mRNA production platform and in vivo transcription, namely, biochemicals for in vitro and in vivo scientific use; Biological preparations for use in industry and science; nucleic acid for laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98153543
Mark Type
No Service Mark
Attorney Docket Number
No 2542-119
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Jul 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 07th May 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 07th May 2024 | PUBLISHED FOR OPPOSITION |
| 17th Apr 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 04th Apr 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 18th Mar 2024 | EXAMINER'S AMENDMENT ENTERED |
| 18th Mar 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 18th Mar 2024 | EXAMINERS AMENDMENT E-MAILED |
| 18th Mar 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 29th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |